Celldex Therapeutics, Inc. Increase (Decrease) in Equity Securities, FV-NI
Celldex Therapeutics, Inc. (CLDX) reported Increase (Decrease) in Equity Securities, FV-NI of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi · last filed 2020-11-05
- Celldex Therapeutics, Inc. increase (decrease) in equity securities, fv-ni for the quarter ending 2020-09-30 was $0.00.
| Period end | Increase (Decrease) in Equity Securities, FV-NI 3 month | Increase (Decrease) in Equity Securities, FV-NI 6 month | Increase (Decrease) in Equity Securities, FV-NI 9 month |
|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |